Real World

Is Hba1C a poor yardstick for determining access to new T1D treatments in the real world

Is Hba1C a poor yardstick for determining access to new T1D treatments in the real world

02/03/2018 admin 1

If you’ve ever looked at a clinical trials document for a type 1 treatment, you’ll nearly always spot two things. Reduction in Hba1C is a […]